{"id":401,"date":"2025-12-01T21:38:46","date_gmt":"2025-12-01T20:38:46","guid":{"rendered":"https:\/\/100blogs.ovh\/36\/index.php\/2025\/12\/01\/who-issues-global-guidance-on-skinny-jabs-like-ozempic-for-obesity-treatment\/"},"modified":"2025-12-01T21:39:14","modified_gmt":"2025-12-01T20:39:14","slug":"who-issues-global-guidance-on-skinny-jabs-like-ozempic-for-obesity-treatment","status":"publish","type":"post","link":"https:\/\/100blogs.ovh\/36\/index.php\/2025\/12\/01\/who-issues-global-guidance-on-skinny-jabs-like-ozempic-for-obesity-treatment\/","title":{"rendered":"WHO issues global guidance on \u2018skinny jabs\u2019 like Ozempic for obesity treatment"},"content":{"rendered":"<div>\n<p><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"682\" src=\"https:\/\/100blogs.ovh\/36\/wp-content\/uploads\/2025\/12\/who-issues-global-guidance-on-skinny-jabs-like-ozempic-for-obesity-treatment-1-1024x682.jpg\" class=\"wp-image-403\" alt=\"\" \/><\/p>\n<p><p>THE WORLD HEALTH ORGANISATION, or WHO, has issued global guidelines on the usage of GLP-1 medicines, also known as \u201cskinny jabs,\u201d in order to treat obesity. The announcement of the guidelines aims \u201cto address the growing global health challenge of obesity, which affects more than 1 billion people,\u201d according to the international organisation. \u201cSkinny jabs,\u201d which include appetite suppressants\u2026<\/p>\n<p><a href=\"https:\/\/euroweeklynews.com\/2025\/12\/01\/who-issues-global-guidance-on-skinny-jabs-like-ozempic-for-obesity-treatment\/\" rel=\"nofollow\">Source<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>THE WORLD HEALTH ORGANISATION, or WHO, has issued global guidelines on the usage of GLP-1 medicines, also known as \u201cskinny jabs,\u201d in order to treat obesity. The announcement of the guidelines aims \u201cto address the growing global health challenge of obesity, which affects more than 1 billion people,\u201d according to the international organisation. \u201cSkinny jabs,\u201d [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-401","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/100blogs.ovh\/36\/index.php\/wp-json\/wp\/v2\/posts\/401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/100blogs.ovh\/36\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/100blogs.ovh\/36\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/100blogs.ovh\/36\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/100blogs.ovh\/36\/index.php\/wp-json\/wp\/v2\/comments?post=401"}],"version-history":[{"count":1,"href":"https:\/\/100blogs.ovh\/36\/index.php\/wp-json\/wp\/v2\/posts\/401\/revisions"}],"predecessor-version":[{"id":404,"href":"https:\/\/100blogs.ovh\/36\/index.php\/wp-json\/wp\/v2\/posts\/401\/revisions\/404"}],"wp:attachment":[{"href":"https:\/\/100blogs.ovh\/36\/index.php\/wp-json\/wp\/v2\/media?parent=401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/100blogs.ovh\/36\/index.php\/wp-json\/wp\/v2\/categories?post=401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/100blogs.ovh\/36\/index.php\/wp-json\/wp\/v2\/tags?post=401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}